Nemaura Medical, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.09%494.441.0%$1073.44m
ABTAbbott Laboratories 1.86%112.910.8%$977.14m
DHRDanaher Corp. -1.00%265.750.7%$820.26m
MDTMedtronic Plc 0.47%125.440.6%$625.70m
ISRGIntuitive Surgical, Inc. -0.37%902.062.3%$454.36m
BDXBecton, Dickinson & Co. 0.14%240.551.0%$384.34m
ALGNAlign Technology, Inc. 2.45%620.646.3%$311.63m
DXCMDexCom, Inc. -0.60%429.137.8%$305.06m
SYKStryker Corp. -0.32%261.811.3%$292.23m
BSXBoston Scientific Corp. 0.37%43.951.0%$278.32m
EWEdwards Lifesciences Corp. -0.20%104.550.4%$240.15m
BAXBaxter International, Inc. 0.57%81.391.8%$239.09m
ZBHZimmer Biomet Holdings, Inc. -0.36%163.881.7%$235.50m
AAgilent Technologies, Inc. -0.10%147.101.6%$235.40m
IDXXIDEXX Laboratories, Inc. -1.10%609.083.8%$213.63m

Company Profile

Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. The sugarBEAT is consist of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.